Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Angeforderte Firma
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Weiterlesen
Small , start-up-like company and lots of opportunity for growth
Was sind einige der besten Dinge an Ihrem Team?
They are intelligent and work hard
Was ist das Beste an Ihrem Vergütungspaket?
Company stock and salary rate
Was ist am positivsten an Kultur und Umgang in Ihrem Unternehmen?
Innovation, opportunity to build and create - career opportunity
Was macht Sie bei der Arbeit am glücklichsten?
Opportunity to build and create
Was braucht das Führungsteam, um besser zu werden?
Imroving the culture of the company, an environment of collaboration and work-life balance
Other Employee Reviews for Karyopharm Therapeutics
×